Supercomputing Grids Close Ranks to Meet Medical Challenge

Two supercomputing networks have successfully joined forces in a distributed simulation of the effectiveness of drugs on mutant strains of the Human Immunodeficiency Virus (HIV). Although the Distributed European Infrastructure for Supercomputing Application (DEISA) and the GridAustralia-Australian Partnership for Advanced Computing (APAC) infrastructures use incompatible underlying platforms (UNICORE 5 and Globus Tool Kit, respectively), the researchers were able to spread the computing tasks over the two high performance computing (HPC) grids.

As HIV is highly mutable, it frequently becomes resistant to drugs that reduce patients' viral loads and bind and inhibit critical viral enzymes. As a result, patients will then have to change their drug regime. It is essential to select the right drug in order to provide the best possible treatment, as well as to prevent the development of further drug resistance.

The simulations run by DEISA and APAC are intended to help this process by testing the effectiveness of particular antiviral drugs against a number of mutant HIV strains. They analyse average interaction energies between anti-HIV drugs and the HIV protease strain, hoping to thus provide an accurate assessment of the drugs' effectiveness.

A huge number of calculations is needed for this, and this is why the process necessitates the processing power of supercomputers. Researchers were sure that time-to-solution would be further reduced by employing several supercomputers in a grid and spreading the tasks over different grids at the same time.

This is the first time that a reliable, automated bidirectional data transfer between the European DEISA grid and the Australian APAC grid has been demonstrated.

For further information, please visit:
http://www.deisa.org

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...